Hagel C, Sloman V, Mynarek M, Petrasch K, et al. Refining M1 stage in medulloblastoma: criteria for cerebrospinal fluid cytology and implications for improved risk stratification from the HIT-2000 trial. Eur J Cancer 2022;164:30-38.
PMID: 35151105